{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:44:38Z","timestamp":1791989078532,"version":"4.4.0"},"reference-count":6,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Symmetrical drug\u2010related intertriginous and flexural exanthema (SDRIFE) is an uncommon type of cutaneous drug eruption, most frequently associated with antibiotics such as amoxicillin. Reports of SDRIFE induced by anticancer agents remain limited. We describe a case of SDRIFE in a 77\u2010year\u2010old man treated with venetoclax for acute myeloid leukemia. The eruption developed shortly after drug initiation and resolved rapidly following drug withdrawal without systemic involvement. Notably, venetoclax was continued for a certain period after onset without progression of symptoms. This case highlights the importance of recognizing SDRIFE in patients receiving chemotherapy and suggests that continuation of the causative agent may be feasible in selected cases.<\/jats:p>","DOI":"10.1111\/1346-8138.70445","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:05:58Z","timestamp":1785823558000},"page":"1385-1387","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Venetoclax\u2010Induced Symmetrical Drug\u2010Related Intertriginous and Flexural Exanthema (\n                    <scp>SDRIFE<\/scp>\n                    ): Implications for Diagnosis and Treatment Continuation"],"prefix":"10.1111","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-5433","authenticated-orcid":false,"given":"Nanako","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Dermatology Kakogawa Central City Hospital  Kakogawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Iso","sequence":"additional","affiliation":[{"name":"Department of Dermatology Kakogawa Central City Hospital  Kakogawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ako","family":"Higashime","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kakogawa Central City Hospital  Kakogawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00445.x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.018"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14090"},{"issue":"6","key":"e_1_2_10_5_1","first-page":"476","article-title":"Malignant Intertrigo: A Subset of Toxic Erythema of Chemotherapy Requiring Recognition","volume":"2","author":"Smith S. M.","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_10_6_1","volume-title":"StatPearls [Internet]","author":"Harbaoui S.","year":"2026"},{"issue":"3","key":"e_1_2_10_7_1","first-page":"238","article-title":"Drug Eruption Considered Symmetrical Drug\u2010Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Paclitaxel","volume":"47","author":"Tanaka R.","year":"2025","journal-title":"Practical Dermatology"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.70445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1346-8138.70445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.70445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:22Z","timestamp":1791985762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.70445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/1346-8138.70445"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.70445","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"2026-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}